{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T20:46:23Z","timestamp":1764103583075,"version":"3.40.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr J"],"DOI":"10.1186\/s12937-025-01115-7","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T20:08:08Z","timestamp":1743192488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of vitamin D and platelet-to-lymphocyte ratio in treatment escalation risk for newly diagnosed Crohn\u2019s disease adults"],"prefix":"10.1186","volume":"24","author":[{"given":"Kan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shichen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingya","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bule","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"issue":"12","key":"1115_CR1","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","volume":"12","author":"GG Kaplan","year":"2015","unstructured":"Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Reviews Gastroenterol Hepatol. 2015;12(12):720\u20137.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"3","key":"1115_CR2","doi-asserted-by":"crossref","first-page":"e065186","DOI":"10.1136\/bmjopen-2022-065186","volume":"13","author":"R Wang","year":"2023","unstructured":"Wang R, et al. Global, regional and National burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the global burden of disease study 2019. BMJ Open. 2023;13(3):e065186.","journal-title":"BMJ Open"},{"key":"1115_CR3","doi-asserted-by":"crossref","first-page":"1032679","DOI":"10.3389\/fpubh.2022.1032679","volume":"10","author":"B Shao","year":"2022","unstructured":"Shao B, Yang W, Cao Q. Landscape and predictions of inflammatory bowel disease in China: China will enter the compounding prevalence stage around 2030. Front Public Health. 2022;10:1032679.","journal-title":"Front Public Health"},{"key":"1115_CR4","doi-asserted-by":"crossref","unstructured":"Hamza FN et al. Immunomodulatory properties of vitamin D in the intestinal and respiratory systems. Nutrients, 2023. 15(7).","DOI":"10.3390\/nu15071696"},{"issue":"3","key":"1115_CR5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0148607110381267","volume":"35","author":"A Ulitsky","year":"2011","unstructured":"Ulitsky A, et al. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enter Nutr. 2011;35(3):308\u201316.","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"1115_CR6","doi-asserted-by":"crossref","unstructured":"Valvano M et al. The usefulness of serum vitamin D levels in the assessment of IBD activity and response to biologics. Nutrients, 2021. 13(2).","DOI":"10.3390\/nu13020323"},{"issue":"4","key":"1115_CR7","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1038\/ctg.2013.1","volume":"4","author":"L Yang","year":"2013","unstructured":"Yang L, et al. Therapeutic effect of vitamin d supplementation in a pilot study of Crohn\u2019s patients. Clin Transl Gastroenterol. 2013;4(4):e33.","journal-title":"Clin Transl Gastroenterol"},{"issue":"11\u201312","key":"1115_CR8","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/apt.15506","volume":"50","author":"J Gubatan","year":"2019","unstructured":"Gubatan J, et al. Systematic review with meta-analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2019;50(11\u201312):1146\u201358.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1115_CR9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/10409238.2019.1611734","volume":"54","author":"MT Cantorna","year":"2019","unstructured":"Cantorna MT, Snyder L, Arora J. Vitamin A and vitamin D regulate the microbial complexity, barrier function, and the mucosal immune responses to ensure intestinal homeostasis. Crit Rev Biochem Mol Biol. 2019;54(2):184\u201392.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"1","key":"1115_CR10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/1751-2980.12565","volume":"19","author":"H Sch\u00e4ffler","year":"2018","unstructured":"Sch\u00e4ffler H, et al. Clinical factors are associated with vitamin D levels in IBD patients: A retrospective analysis. J Dig Dis. 2018;19(1):24\u201332.","journal-title":"J Dig Dis"},{"key":"1115_CR11","doi-asserted-by":"crossref","unstructured":"Wienkamp A-K, Erpenbeck L, Rossaint J. Platelets in the networks interweaving inflammation and thrombosis. Front Immunol, 2022. 13.","DOI":"10.3389\/fimmu.2022.953129"},{"issue":"1","key":"1115_CR12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12272-020-01296-1","volume":"44","author":"D Anka Idrissi","year":"2021","unstructured":"Anka Idrissi D, et al. IL-1 and CD40\/CD40L platelet complex: elements of induction of Crohn\u2019s disease and new therapeutic targets. Arch Pharm Res. 2021;44(1):117\u201332.","journal-title":"Arch Pharm Res"},{"issue":"1","key":"1115_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12672-024-00956-8","volume":"15","author":"L Qin","year":"2024","unstructured":"Qin L. The predictive value of NLR, PLR and MLR in the differential diagnosis of benign uterine diseases and endometrial malignant tumors. Discov Oncol. 2024;15(1):91.","journal-title":"Discov Oncol"},{"key":"1115_CR14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.lungcan.2017.07.024","volume":"111","author":"S Diem","year":"2017","unstructured":"Diem S, et al. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer. 2017;111:176\u201381.","journal-title":"Lung Cancer"},{"key":"1115_CR15","first-page":"p7971415","volume":"2022","author":"W Chen","year":"2022","unstructured":"Chen W, Xin S, Xu B. Value research of NLR, PLR, and RDW in prognostic assessment of patients with colorectal cancer. J Healthc Eng. 2022;2022:p7971415.","journal-title":"J Healthc Eng"},{"key":"1115_CR16","doi-asserted-by":"crossref","unstructured":"Chen YH et al. The Relationship between C-Reactive Protein\/Albumin Ratio and Disease Activity in Patients with Inflammatory Bowel Disease. Gastroenterol Res Pract, 2020. 2020: p. 3467419.","DOI":"10.1155\/2020\/3467419"},{"issue":"9","key":"1115_CR17","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1007\/s00431-023-05110-0","volume":"182","author":"A Zahmatkesh","year":"2023","unstructured":"Zahmatkesh A, et al. The role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in the diagnosis and severity of inflammatory bowel disease in children. Eur J Pediatr. 2023;182(9):4263\u201370.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"1115_CR18","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s10753-023-01796-4","volume":"46","author":"I Soufli","year":"2023","unstructured":"Soufli I, et al. Nitric oxide, neutrophil\/lymphocyte, and platelet\/lymphocyte ratios as promising inflammatory biomarkers in complicated Crohn\u2019s disease: outcomes of corticosteroids and Anti-TNF-\u03b1 therapies. Inflammation. 2023;46(3):1091\u2013105.","journal-title":"Inflammation"},{"key":"1115_CR19","unstructured":"Inflammatory Bowel Disease Group. C.S.o.G., Chinese medical association and I.B.D.Q.C.C.o. China, Chinese clinical practice guideline on the management of Crohn\u2019s disease (2023, Guangzhou). Chin J Inflamm Bowel Dis, 2024(01): pp. 2\u201332."},{"issue":"Suppl 2","key":"1115_CR20","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/ibd\/izab327","volume":"28","author":"L Yao","year":"2022","unstructured":"Yao L, et al. Temporal changes in the treatment paradigm and Long-term prognosis of patients with Crohn\u2019s disease: A Hospital-Based cohort study in China. Inflamm Bowel Dis. 2022;28(Suppl 2):S25\u201334.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"1115_CR21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","volume":"10","author":"M Harbord","year":"2016","unstructured":"Harbord M, et al. The first European Evidence-based consensus on Extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10(3):239\u201354.","journal-title":"J Crohns Colitis"},{"issue":"5","key":"1115_CR22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"key":"1115_CR23","doi-asserted-by":"crossref","unstructured":"Silverberg MS et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal world Congress of gastroenterology. Can J Gastroenterol, 2005. 19 Suppl A: p. a5\u201336.","DOI":"10.1155\/2005\/269076"},{"issue":"3","key":"1115_CR24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","volume":"70","author":"WR Best","year":"1976","unstructured":"Best WR, et al. Development of a Crohn\u2019s disease activity index. National cooperative Crohn\u2019s disease study. Gastroenterology. 1976;70(3):439\u201344.","journal-title":"Gastroenterology"},{"issue":"3","key":"1115_CR25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266\u201381.","journal-title":"N Engl J Med"},{"issue":"1","key":"1115_CR26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jan.15476","volume":"79","author":"J Fletcher","year":"2023","unstructured":"Fletcher J, et al. Prevalence of vitamin D deficiency and modifiable risk factors in patients with Crohn\u2019s disease: A prospective observational study. J Adv Nurs. 2023;79(1):205\u201314.","journal-title":"J Adv Nurs"},{"key":"1115_CR27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jsbmb.2016.12.015","volume":"175","author":"JH White","year":"2018","unstructured":"White JH. Vitamin D deficiency and the pathogenesis of Crohn\u2019s disease. J Steroid Biochem Mol Biol. 2018;175:23\u20138.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"12","key":"1115_CR28","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1210\/me.2003-0281","volume":"17","author":"M Froicu","year":"2003","unstructured":"Froicu M, et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol. 2003;17(12):2386\u201392.","journal-title":"Mol Endocrinol"},{"issue":"6 Suppl","key":"1115_CR29","doi-asserted-by":"crossref","first-page":"s1717","DOI":"10.1093\/ajcn\/80.6.1717S","volume":"80","author":"MT Cantorna","year":"2004","unstructured":"Cantorna MT, et al. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004;80(6 Suppl):s1717\u201320.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"1115_CR30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2036.2010.04355.x","volume":"32","author":"SP J\u00f8rgensen","year":"2010","unstructured":"J\u00f8rgensen SP, et al. Clinical trial: vitamin D3 treatment in Crohn\u2019s disease - a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther. 2010;32(3):377\u201383.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"1115_CR31","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/ajg.2016.53","volume":"111","author":"TA Kabbani","year":"2016","unstructured":"Kabbani TA, et al. Association of vitamin D level with clinical status in inflammatory bowel disease: A 5-Year longitudinal study. Am J Gastroenterol. 2016;111(5):712\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"1115_CR32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/0148607113504002","volume":"38","author":"ZA Zator","year":"2014","unstructured":"Zator ZA, et al. Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-\u03b1 therapy in inflammatory bowel diseases. JPEN J Parenter Enter Nutr. 2014;38(3):385\u201391.","journal-title":"JPEN J Parenter Enter Nutr"},{"issue":"1","key":"1115_CR33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/eji.200425491","volume":"35","author":"Y Zhu","year":"2005","unstructured":"Zhu Y, et al. Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol. 2005;35(1):217\u201324.","journal-title":"Eur J Immunol"},{"issue":"8","key":"1115_CR34","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.1601708","volume":"198","author":"C Zamora","year":"2017","unstructured":"Zamora C, et al. Binding of platelets to lymphocytes: A potential Anti-Inflammatory therapy in rheumatoid arthritis. J Immunol. 2017;198(8):3099\u2013108.","journal-title":"J Immunol"},{"issue":"1","key":"1115_CR35","first-page":"2755","volume":"21","author":"MMD Al-Rshaidat","year":"2023","unstructured":"Al-Rshaidat MMD, et al. Evaluating the clinical application of the immune cells\u2019 ratios and inflammatory markers in the diagnosis of inflammatory bowel disease. Pharm Pract (Granada). 2023;21(1):2755.","journal-title":"Pharm Pract (Granada)"},{"issue":"1","key":"1115_CR36","first-page":"127","volume":"24","author":"MK Wlodarczyk","year":"2015","unstructured":"Wlodarczyk MK, et al. Neutrophil-lymphocyte ratio in Crohn\u2019s disease patients predicts sustained response to Infliximab 52-week therapy. J Gastrointestin Liver Dis. 2015;24(1):127\u20138.","journal-title":"J Gastrointestin Liver Dis"},{"key":"1115_CR37","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.2147\/JIR.S321362","volume":"14","author":"A Alharbi","year":"2021","unstructured":"Alharbi A. A potential role of vitamin D on platelet leukocyte aggregation and pathological events in sepsis: an updated review. J Inflamm Res. 2021;14:3651\u201364.","journal-title":"J Inflamm Res"},{"issue":"4","key":"1115_CR38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3343\/alm.2019.39.4.345","volume":"39","author":"AY Gasparyan","year":"2019","unstructured":"Gasparyan AY, et al. The Platelet-to-Lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med. 2019;39(4):345\u201357.","journal-title":"Ann Lab Med"},{"issue":"30","key":"1115_CR39","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.3748\/wjg.v28.i30.4102","volume":"28","author":"LY Yao","year":"2022","unstructured":"Yao LY, et al. Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease. World J Gastroenterol. 2022;28(30):4102\u201319.","journal-title":"World J Gastroenterol"}],"container-title":["Nutrition Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-025-01115-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12937-025-01115-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-025-01115-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T20:09:05Z","timestamp":1743192545000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionj.biomedcentral.com\/articles\/10.1186\/s12937-025-01115-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1115"],"URL":"https:\/\/doi.org\/10.1186\/s12937-025-01115-7","relation":{},"ISSN":["1475-2891"],"issn-type":[{"value":"1475-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethical review committee of the Sir Run Run Shaw Hospital, School of Medicine Zhejiang University (20210330-42).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}